- NCIt
- C5329
Loading cancer entity…
Loading cancer entity…
Clinical trials
2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06408402 | Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers(PGLEXPO2) | recruiting | — | 1,300 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Jul 9, 2026source: clinicaltrials